Study on the Recovery of Pulmonary Function Chest CT Hematologic and Immune & Inflammatory Conditions in COVID-19 Rehabilitation Patients

  • STATUS
    Recruiting
  • End date
    Jun 1, 2022
  • participants needed
    240
  • sponsor
    Wuhan Union Hospital, China
Updated on 25 January 2021
covid-19
SARS
chest ct
coronavirus infection

Summary

The intent of this study was to examine the recovery of individuals who had been hospitalized for COVID-19 in the year following their discharge from the hospital. Parameters studied included serum levels of SARS coronavirus 2 (SARS-CoV 2) IgG antibody, tests of lung function, and imaging data to evaluate changes in lung fibrosis. In addition, we explored the systematic Immune & Inflammation in some of the individuals recovering from COVID-19.

Description

About 20% of COVID-19 developed into a critical illness and about 2% died. The global epidemic continues to develop, but some patients in China have entered the rehabilitation period, which is accompanied by a large number of respiratory symptoms and pulmonary fibrosis, bringing serious harm to the country. Therefore, early accurate detection and prediction of the development trend of patients in rehabilitation period and targeted treatment measures for corresponding patients are the key to the success of COVID-19 rehabilitation period. It will play a key role in the stratified management of the post-epidemic situation, which is crucial to improve the quality of life of COVID-19 patients. We aim to explore the clinical characteristics of rehabilitation patients by detecting some indicators of patients in rehabilitation period, including serum IgG and IgM antibody of SARS-CoV 2, pulmonary function, chest CT imaging, systematic Immune & Inflammation states.

Details
Condition *COVID-19, Covid-19
Clinical Study IdentifierNCT04456101
SponsorWuhan Union Hospital, China
Last Modified on25 January 2021

Eligibility

Yes No Not Sure

Inclusion Criteria

Inpatients recovering from severe/critical COVID-19, or asymptomatic COVID-19 patients with laboratory test for SRARS-COV2 turning negative,or healthy volunteers without COVID-19
The age range is 18-80 years
Subjects or their family members agree to participate in the study and sign informed consent
The previously diagnosed inpatients have been cured and discharged from hospital for about 3 months
without other underlying lung diseases

Exclusion Criteria

Woman who is breastfeeding, pregnant, or preparing to become pregnant
Patients with other underlying lung diseases
Patients with cognitive impairment or poor compliance as determined by the investigator
Participants in other clinical trials within three months
Subjects who were not suitable for clinical trials determined by the investigator
\-
Clear my responses

How to participate?

Step 1 Connect with a study center
What happens next?
  • You can expect the study team to contact you via email or phone in the next few days.
  • Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

Investigator Avatar

Primary Contact

site

0/250

Additional screening procedures may be conducted by the study team before you can be confirmed eligible to participate.

Learn more

If you are confirmed eligible after full screening, you will be required to understand and sign the informed consent if you decide to enroll in the study. Once enrolled you may be asked to make scheduled visits over a period of time.

Learn more

Complete your scheduled study participation activities and then you are done. You may receive summary of study results if provided by the sponsor.

Learn more

Similar trials to consider

Loading...

Browse trials for

Not finding what you're looking for?

Every year hundreds of thousands of volunteers step forward to participate in research. Sign up as a volunteer and receive email notifications when clinical trials are posted in the medical category of interest to you.

Sign up as volunteer

user name

Added by • 

 • 

Private

Reply by • Private
Loading...

Lorem ipsum dolor sit amet consectetur, adipisicing elit. Ipsa vel nobis alias. Quae eveniet velit voluptate quo doloribus maxime et dicta in sequi, corporis quod. Ea, dolor eius? Dolore, vel!

  The passcode will expire in None.
Loading...

No annotations made yet

Add a private note
  • abc Select a piece of text from the left.
  • Add notes visible only to you.
  • Send it to people through a passcode protected link.
Add a private note